Our results suggest that inhibiting miR-653-5p restricts the proliferation and invasion of prostate cancer cells due to the inhibition of Wnt/β-catenin signaling through the miRNA’s targeting of SOX30. This evidence concerns the gene SOX30 and prostate carcinoma.